DiaSorin S.p.A.
General ticker "DSRLF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $5.7B (TTM average)
DiaSorin S.p.A. does not follow the US Stock Market performance with the rate: -34.5%.
Estimated limits based on current volatility of 0.4%: low 68.66$, high 69.33$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-20, amount 1.41$ (Y2.03%)
Short-term DSRLF quotes
Long-term DSRLF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €1,361.14MM | €1,148.21MM | €1,185.43MM |
| Operating Expenses | €1,009.88MM | €931.95MM | €927.10MM |
| Operating Income | €351.26MM | €216.26MM | €258.32MM |
| Non-Operating Income | €-25.32MM | €-15.04MM | €-15.88MM |
| Interest Expense | €34.97MM | €29.34MM | €28.61MM |
| R&D Expense | €96.90MM | €90.95MM | €91.57MM |
| Income(Loss) | €325.94MM | €201.22MM | €242.45MM |
| Taxes | €85.83MM | €42.71MM | €55.39MM |
| Profit(Loss)* | €240.91MM | €159.85MM | €188.10MM |
| Stockholders Equity | €1,518.99MM | €1,538.61MM | €1,800.92MM |
| Inventory | €306.50MM | €315.50MM | €344.04MM |
| Assets | €3,408.08MM | €3,211.44MM | €3,304.92MM |
| Operating Cash Flow | €389.34MM | €311.66MM | €358.78MM |
| Capital expenditure | €113.69MM | €45.47MM | €119.72MM |
| Investing Cash Flow | €-231.95MM | €-29.10MM | €-49.81MM |
| Financing Cash Flow | €-333.04MM | €-235.96MM | €-259.13MM |
| Earnings Per Share** | €4.17 | €2.87 | €3.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.